GEN PROBE INC (GPRO) [Rocket]

News + Filings

All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Credit agrmnt [a]
Quarterly results
Appointed director
CC transcript

GEN PROBE INC (GPRO)

Create: Alert

All | News | Filings

Date Filed	Type	Description
05/08/2012	PRN	FDA Clears Gen-Probe's PANTHER® System for use with APTIMA Combo 2® Assay
05/03/2012	PRN	Gen-Probe Withdraws from Previously Announced Investor Presentations
04/30/2012	PRN	Gen-Probe Reports Financial Results for the First Quarter of 2012
02/22/2012	PRN	Gen-Probe to Webcast Four Upcoming Investor Presentations
12/09/2011	PRN	Gen-Probe to Webcast Presentation at the Oppenheimer 22nd Annual Healthcare Conference
11/11/2011	PRN	Gen-Probe to Webcast Three Upcoming Investor Presentations
11/02/2011	PRN	Gen-Probe Reports Financial Results for the Third Quarter of 2011
10/31/2011	PRN	FDA Approves Gen-Probe's APTIMA® HPV Assay, New Molecular Test to Detect Virus that Causes Cervical Cancer
10/11/2011	PRN	Gen-Probe Announces Webcast of Third Quarter 2011 Earnings Conference Call
05/20/2011	PRN	Gen-Probe Files for US Regulatory Clearance of PANTHER™ System, Fully Automated and Integrated Molecular Testing Instrument
04/28/2011	PRN	Gen-Probe Reports Financial Results for the First Quarter of 2011
04/20/2011	PRN	FDA Clears First Nucleic Acid Amplification Test to Detect Common Sexually Transmitted Infection Trichomonas Vaginalis
04/14/2011	PRN	Gen-Probe Announces Webcast of First Quarter 2011 Earnings Conference Call
02/24/2011	PRN	Gen-Probe to Webcast Three Upcoming Investor Presentations
02/24/2011	PRN	Gen-Probe to Webcast Three Upcoming Investor Presentations
02/15/2011	PRN	Gen-Probe Reports Financial Results for the Fourth Quarter and Full Year 2010
02/15/2011	PRN	Gen-Probe Announces $150 Million Stock Repurchase Plan
07/29/2010	PRN	Gen-Probe Reports Financial Results for the Second Quarter of 2010
07/26/2010	PRN	FDA Clears Prodesse's ProFAST™+ Assay to Identify Three Strains of Influenza A, Including 2009 H1N1
06/30/2010	PRN	Gen-Probe Receives European CE Mark for Molecular Test to Detect Common Sexually Transmitted Disease Trichomonas Vaginalis
06/18/2010	PRN	Gen-Probe to Webcast Presentation at the Fifth Annual Piper Jaffray Europe Conference
06/17/2010	PRN	Gen-Probe Makes $50 Million Strategic Investment in Third Generation Sequencing Company Pacific Biosciences
06/10/2010	PRN	Gen-Probe to Webcast Two Upcoming Investor Presentations
04/22/2010	PRN	PROGENSA(R) PCA3 Assay Can Help Predict Outcome of Initial Prostate Biopsies, According to Study Presented at Leading Urology Meeting
03/22/2010	PRN	Brian McNamee Elected to Gen-Probe Board of Directors

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy